KRYS News and Press, Krystal Biotech Inc. From 01/04/24

PITTSBURGH, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs, toda...

PITTSBURGH, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs, toda...

2023-12-16 16:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-11 01:03:08 ET Summary Krystal Biotech's Vyjuvek shows strong early sales for DEB treatment, indicating market acceptance and revenue potential. Financially, Krystal is robust with $598.5M in liquid assets and a low risk of near-term financing needs. Market sentiment i...

If approved, ~3,000 people with DEB in the European Union could receive VYJUVEK to treat the underlying cause of the disease for the first time VYJUVEK received Orphan Drug Designation and PRIME designation from the EMA PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- ...

2023-11-20 15:03:53 ET More on Krystal Biotech Krystal Biotech Inc. (KRYS) Q3 2023 Earnings Call Transcript Krystal Biotech: FDA Approval Of Vyjuvek And Further Pipeline Enhancement Krystal Biotech Q3 2023 Earnings Preview Cantor starts Krystal Biotech at ove...

2023-11-10 06:55:00 ET It's been a solid year for Krystal Biotech (NASDAQ: KRYS) , a midcap company focusing on developing gene therapies, as it has easily outperformed the market this year. However, zooming out tells an even more impressive story: In the past five years, its shares...

2023-11-09 11:33:03 ET More on Markets Cracks starting to appear in U.S. economy, especially in residential home market – Wells Fargo Morningstar Research calls for the slowing rate of economic growth We are in the early stages of what will be a supercycle in ...

PITTSBURGH, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs, anno...

2023-11-06 11:43:02 ET Krystal Biotech Inc. (KRYS) Q3 2023 Earnings Conference Call November 06, 2023 08:30 A.M. ET Company Participants Meg Dodge - VP, Investor Relations & Corporate Communications Krish Krishnan - Chairman & Chief Executive Officer Suma...